ENPP2 and obesity due to melanocortin 4 receptor deficiency: Our results argued that EMP treatment significantly downregulated the expression level of Cpped1. ENPP2 is an important mediator of adipose tissue obesity, and adipocyte-specific deletion of Enpp2 ameliorated glucose and insulin intolerance induced by an HFD (32).